Nils Rettby

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

François Spertini, R Audran, Reza Chakour et al. · The Lancet Respiratory Medicine · 2015 · 174 citations · Full text

Vaccination, Vaccine Safety, Pulmonary Tuberculosis +8

Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial

Matteo Mombelli, Nils Rettby, Matthieu Perreau et al. · Vaccine · 2018 · 53 citations

Vaccinology, Vaccine Safety, Vaccination +10

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

Giuseppe Pantaleo, Holly Janes, Shelly Karuna et al. · The Lancet HIV · 2019 · 50 citations · Full text

Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™

Paul Vescovo, Nils Rettby, Nirinarilala Ramaniraka et al. · Vaccine · 2017 · 39 citations · Full text

Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell <scp>non‐Hodgkin</scp> lymphoma

Shinichi Makita, Go Yamamoto, Dai Maruyama et al. · Cancer Medicine · 2022 · 23 citations · Full text